This program is located in a public school and, therefore, the program may not be responsible for correcting the violation.
| Date |
Inspection Type |
Inspection ID |
Inspection Result |
|
|
Feb 19, 2026 |
Annual Unannounced |
2026-I-YRO-001144
|
No violations cited for this Inspection |
|
|
Oct 14, 2025 |
Monitoring |
2025-I-YRO-107976
|
No violations cited for this Inspection |
|
|
Sep 11, 2025 |
Monitoring |
2025-I-YRO-100356
|
No violations cited for this Inspection |
|
|
May 7, 2025 |
Annual Unannounced |
2025-I-YRO-001963
|
No violations cited for this Inspection |
|
|
Jan 27, 2025 |
Monitoring |
2025-I-YRO-020861
|
No violations cited for this Inspection |
|
|
Oct 30, 2024 |
Annual Unannounced |
2024-I-YRO-001571
|
Violations Found
|
|
|
|
|
| Regulation |
Description |
Compliance Status |
| 414.11(f)(7)(ii) |
Prescription medications, oral over-the-counter medications, medicated patches, and eye, ear, or nasal drops or sprays, can be administered by the program for one day only, with the verbal permission of the parent. If prescription medications, oral over-the-counter medications, medicated patches, and eye, ear, or nasal drops or sprays are to be administered on a subsequent day or an ongoing basis, written permission from the parent and written instructions from the health care provider must have been provided to the program prior to such administration. |
Corrected |
| 414.13(d)(3) |
With the prior written approval of the Office, a staff person who is qualified to perform program supervision functions may perform such functions at up to four different programs operated by a single agency. In order to obtain Office approval, the agency will be required to demonstrate how the staff person will provide adequate supervision and program development support to each site. |
Corrected |
|
|
Sep 11, 2024 |
Monitoring |
2024-I-YRO-084696
|
No violations cited for this Inspection |
|
|
May 6, 2024 |
Monitoring |
2024-I-YRO-045116
|
No violations cited for this Inspection |
|